AU3987195A - Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections - Google Patents

Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections

Info

Publication number
AU3987195A
AU3987195A AU39871/95A AU3987195A AU3987195A AU 3987195 A AU3987195 A AU 3987195A AU 39871/95 A AU39871/95 A AU 39871/95A AU 3987195 A AU3987195 A AU 3987195A AU 3987195 A AU3987195 A AU 3987195A
Authority
AU
Australia
Prior art keywords
rifabutin
atovaquone
treatment
combination
pneumocystis carinii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39871/95A
Inventor
John Charles William Comley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU3987195A publication Critical patent/AU3987195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39871/95A 1994-11-29 1995-11-29 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections Abandoned AU3987195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9424013 1994-11-29
GB9424013A GB9424013D0 (en) 1994-11-29 1994-11-29 Medicaments
PCT/GB1995/002790 WO1996016652A2 (en) 1994-11-29 1995-11-29 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections

Publications (1)

Publication Number Publication Date
AU3987195A true AU3987195A (en) 1996-06-19

Family

ID=10765105

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39871/95A Abandoned AU3987195A (en) 1994-11-29 1995-11-29 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections

Country Status (5)

Country Link
EP (1) EP0794776A2 (en)
JP (1) JPH10509722A (en)
AU (1) AU3987195A (en)
GB (1) GB9424013D0 (en)
WO (1) WO1996016652A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015218949A1 (en) 2014-02-19 2016-10-06 The Texas A&M University System Compositions and methods for drug sensitization of parasites

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
ATE143601T1 (en) * 1993-05-05 1996-10-15 Palo Alto Medical Found USE OF RIFAMYCIN DERIVATIVES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF TOXOPLASMOSIS

Also Published As

Publication number Publication date
WO1996016652A2 (en) 1996-06-06
GB9424013D0 (en) 1995-01-18
EP0794776A2 (en) 1997-09-17
WO1996016652A3 (en) 1996-08-15
JPH10509722A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
GB2274901B (en) Suction catheter assemblies and valves
GB2271829B (en) Suction catheter assemblies and valves
NZ314903A (en) A peg-ifn alpha conjugate and its use in the treatment of immunomodulatory disorders
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AUPM279393A0 (en) Estimation of flow and detection of breathing in cpap treatment
AU6897198A (en) Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
ZA947138B (en) Skin care method and composition
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU4131597A (en) Sulfated polysaccharides and uses thereof in medical treatment
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
HUT74608A (en) Biologically active silicon-compounds and their pharmaceutical and cosmetical use
AU4312393A (en) Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract
AU3987195A (en) Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections
AU691528B2 (en) Estimation of flow and detection of breathing in CPAP treatment
AU2992492A (en) The use of d-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects
Hunter Modern and ancient coral associations of the Cayman Islands
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
IL127350A0 (en) Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
ZA947139B (en) Skin care method and composition
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
IL109356A0 (en) N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones
AU7101696A (en) Diester and the use thereof as hydrophilising agent in pvc